Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 3284 entries
View as:

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.

Phase: N/A Priority: Normal
NCT ID: NCT00799747 Org: User:
Start: 12/31/08 End: 04/30/09 Due: 04/30/10

NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT06494540 Org: User:
Start: 06/28/24 End: 06/30/28 Due: 06/30/29

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Phase: N/A Priority: Normal
NCT ID: NCT00239681 Org: User:
Start: 02/28/03 End: 09/30/08 Due: 09/30/09

Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01493544 Org: User:
Start: 02/29/12 End: 10/31/12 Due: 10/31/13

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

Phase: N/A Priority: Normal
NCT ID: NCT01425814 Org: User:
Start: 08/31/11 End: 03/31/12 Due: 03/31/13

Ulcer Prevention II

Phase: N/A Priority: Normal
NCT ID: NCT00629928 Org: User:
Start: 02/28/01 End: 03/31/03 Due: 03/31/04

An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01201980 Org: User:
Start: 12/31/10 End: 12/31/11 Due: 12/31/12

Renal Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT00863161 Org: User:
Start: 03/31/09 End: 02/28/10 Due: 02/28/11

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02814656 Org: User:
Start: 06/22/16 End: 11/28/16 Due: 11/28/17

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04769869 Org: User:
Start: 07/08/22 End: 01/24/23 Due: 01/24/24

Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT04466969 Org: User:
Start: 07/31/20 End: 11/30/20 Due: 11/30/21

Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03616821 Org: User:
Start: 08/07/18 End: 10/23/23 Due: 10/23/24

A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01068184 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

Assess Safety, Tolerability and PK of AZD3199 in Japanese

Phase: N/A Priority: Normal
NCT ID: NCT00772759 Org: User:
Start: 10/31/08 End: 02/28/09 Due: 02/28/10

Assess the Efficacy and Safety of Rhinocort Aqua

Phase: N/A Priority: Normal
NCT ID: NCT00641693 Org: User:
Start: 04/30/04 End: 05/31/05 Due: 05/31/06

Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT01169727 Org: User:
Start: 07/31/10 End: 03/31/12 Due: 03/31/13

Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00660803 Org: User:
Start: 05/31/08 End: 04/30/09 Due: 04/30/10

Fasenra Pediatric Japan Post-Marketing Study(PMS)

Phase: N/A Priority: Normal
NCT ID: NCT06427876 Org: User:
Start: 07/16/24 End: 03/17/27 Due: 03/17/28

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02978482 Org: User:
Start: 12/01/16 End: 11/26/20 Due: 11/26/21

C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Phase: N/A Priority: Normal
NCT ID: NCT00921752 Org: User:
Start: 05/31/09 End: 11/30/09 Due: 11/30/10

Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT04667312 Org: User:
Start: 06/24/21 End: 09/28/22 Due: 09/28/23

A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01938612 Org: User:
Start: 09/12/13 End: 11/25/20 Due: 11/25/21

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06122714 Org: User:
Start: 11/07/23 End: 12/04/24 Due: 12/04/25

A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00999895 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium

Phase: N/A Priority: Normal
NCT ID: NCT03682497 Org: User:
Start: 11/01/18 End: 03/31/20 Due: 03/31/21